J2505 — Injection, pegfilgrastim, 6 mg
J2505 is a HCPCS Level II code for injection, pegfilgrastim, 6 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2021 and is not valid on new claims.
This code has been terminated
CMS terminated J2505 on December 31, 2021. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J2505
- Long descriptor
- Injection, pegfilgrastim, 6 mg
- Short descriptor
- Injection, pegfilgrastim 6mg
- Added
- January 1, 2004
- Terminated
- December 31, 2021
- BETOS
- O1E
- Pricing indicator
- 53 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Statute.
Codes adjacent to J2505
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J2505 is not quite right, the correct code is very often within a few positions of it.
- J2469Injection, palonosetron hcl, 25 mcg
- J2470Injection, pantoprazole sodium, 40 mg
- J2471Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg
- J2472Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg
- J2501Injection, paricalcitol, 1 mcg
- J2502Injection, pasireotide long acting, 1 mg
- J2503Injection, pegaptanib sodium, 0.3 mgterminated
- J2504Injection, pegademase bovine, 25 iuterminated
- J2506Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507Injection, pegloticase, 1 mg
- J2508Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2513Injection, pentastarch, 10% solution, 100 mlterminated
- J2515Injection, pentobarbital sodium, per 50 mg
- J2516Injection, pentamidine isethionate, 1 mg
- J2540Injection, penicillin g potassium, up to 600,000 units
Questions about J2505
What is HCPCS code J2505?
J2505 is a HCPCS Level II code for injection, pegfilgrastim, 6 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J2505?
The CMS HCPCS file marks J2505 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J2505 still valid?
No. J2505 was terminated on December 31, 2021 and should not be used on new claims.